Primary Record
kavain
- In stock
- 5,585 g
- Purity
- 98.5 %
- CAS
- 3155-48-4
Compound Identifiers & Properties
- CAS
- 3155-48-4
- PubChem CID
- 5369129
- SMILES
- COC1=CC(=O)OC(C1)/C=C/C2=CC=CC=C2
- Canonical SMILES
- COC1=CC(=O)OC(/C=C/c2ccccc2)C1
Names & Synonyms
- kavain
- Kawain
- Neuronica
- DL-KAWAIN
- DL-Kavain
- Cavain
- rac-Kavain
- kavaine
- Kavain, dl-
- Gonosan
- 3155-48-4
- D-Kawain
- D,L-Kawin
- (+/-)-Kavain
- Kawain, DL-
- (+/-)-kawain
- Kavain (Standard)
- Kawain (+-)-form
- Prestwick_556
- D,L-KAWAIN
- (-)-Kawain
- (+-)-kavain
- (+-)-kawain
- AC1NSSDI
- 5L1NI60TGB
- UNII-5L1NI60TGB
- Kavain (+/-)
- AC1Q6BDK
- Opera_ID_1395
- RefChem:792642
- Kawain, (+-)-
- D0L1WV
- kavain, (R)-(E)-isomer
- MLS000069449
- CCRIS 9373
- BSPBio_001184
- CHEMBL1482039
- MLS001148390
- SCHEMBL515203
- DTXSID00904756
- DL-Kavain, analytical standard
- XEAQIWGXBXCYFX-BQYQJAHWSA-N
- C14H14O3
- CHEBI:91863
- HY-N2096R
- DTXCID60209512
- KAWAIN, (+/-)-
- CHEBI:156288
- MFCD00270446
- HMS1362L05
- HMS1792L05
- HMS1990L05
- HMS2232L23
- HMS3403L05
- DL-KAVAIN (REFERENCE GRADE)
- HY-N2096
- EINECS 207-907-2
- AR-1G3107
- BDBM50635854
- KAWAIN (+/-)-FORM [MI]
- SMR000059008
- AKOS015903213
- (E)-4-methoxy-6-styryl-5,6-dihydro-2H-pyran-2-one
- C14-H14-O3
- CCG-208228
- CID5369129
- EBC-616728
- EBC-618493
- FK65645
- LS-2119
- NSC 112162
- 1635-33-2
- IDI1_002187
- NCGC00018126-02
- NCGC00018126-03
- NCGC00018126-04
- NCGC00089781-02
- NCGC00089781-03
- AS-75955
- ST097626
- 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-[(1E)-2-phenylethenyl]-
- LS-127434
- 4-methoxy-2-[(E)-2-phenylethenyl]-2,3-dihydropyran-6-one
- 4-methoxy-6-(2-phenylethenyl)-5,6-dihydro-2h-pyran-2-one
- 4-Methoxy-6-styryl-5,6-dihydro-2H-pyran-2-one
- CS-0018617
- FT-0777732
- 4-methoxy-6-styryl-5,6-dihydro-pyran-2-one
- J1.892.684I
- J2.647.246F
- 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-styryl-
- 155K484
- 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-(2-phenylethenyl)-
- SR-01000003014
- 4-methoxy-2-[(E)-styryl]-2,3-dihydropyran-6-one
- 4-methoxy-6-[(1E)-2-phenylethenyl]-5,6-dihydro-2H-pyran-2-one
- DL-Kavain, primary pharmaceutical reference standard
- KAWAIN (KAVA KAVA (CAS: 9000-38-8))
- SR-01000003014-4
- (R)-5,6-Dihydro-4-methoxy-6-styryl-2H-pyran-2-one
- BRD-A75455249-001-02-0
- BRD-A75455249-001-12-9
- I14-18787
- Q27262508
- 4-Methoxy-6-[(E)-styryl]-5,6-dihydro-2H-pyran-2-one
- trans-5,6-Dihydro-4-methoxy-6-(2-phenylethenyl)-2H-pyran-2-one
- (R-(E))-5,6-Dihydro-4-methoxy-6-styryl-2H-pyran-2-one
- 2,6-Heptadienoic acid, 5-hydroxy-3-methoxy-7-phenyl-, delta-lactone
- 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-styryl-, (+)-
- 4-Methoxy-6-(beta-phenylvinyl)-5,6-dihydro-alpha-pyrone
- 4-methoxy-6-[(e)-2-phenylethenyl]-5,6-dihydropyran-2-one
- 5,6-Dihydro-4-methoxy-6-[(1E)-2-phenylethenyl]-2H-pyran-2-one
- 6-((1E)-2-phenylvinyl)-4-methoxy-5H-6-hydropyran-2-one
- 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-styryl-, (.+.)-
- 5,6-Dihydro-4-methoxy-6-(2-phenylethenyl)-2H-pyran-2-one
- 500-64-1
- 2H-PYRAN-2-ONE, 5,6-DIHYDRO-4-METHOXY-6-STYRYL-, (R)-
- 2H-Pyran-2-one,5,6-dihydro-4-methoxy-6-[(1E)-2-phenylethenyl]-
- 4-Methoxy-6-[(E)-2-phenylethen-1-yl]-5,6-dihydro-2H-pyran-2-one
- 5,6-Dihydro-4-methoxy-6-((1E)-2-phenylethenyl)-2H-pyran-2-one
- 5-Hydroxy-3-methoxy-7-phenyl-2,6-heptadienoic acid gamma-lactone
- 2H-PYRAN-2-ONE, 5,6-DIHYDRO-4-METHOXY-6-((1E)-2-PHENYLETHENYL)-
- 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-(2-phenylethenyl)-, (E)-(+-)-
- 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-(2-phenylethenyl)-, (R-(E))-
- 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-(2-phenylethenyl)-, (E)-(.+.)-
- trans-5,6-Dihydro-4-methoxy-6-(2-phenylethenyl)-2H-pyran-2-one, DL-Kawain
- 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-[(1E)-2-phenylethenyl]-; 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-(2-phenylethenyl)-, (E)-(+/-)-; 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-styryl-, (+/-)- (8CI); (+/-)-Kavain; (+/-)-Kawain; 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-(2-phenylethenyl)-, (E)-; DL-Kawain; dl-Kavain
- 51946-14-6
- 626-921-3